Dental Care Clinics in Roslyn Heights, NY Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Al Dente Dental Of Roslyn, P.c. Dentist Medicare: Not Enrolled in Medicare Practice Location: 70 Glen Cove Rd Ste 103, Roslyn Heights, NY 11577 Phone: 516-499-5393 Fax: 516-499-5393 |
Roslyn Family Dental, P.c. Dentist Medicare: Not Enrolled in Medicare Practice Location: 86 Mineola Ave, Roslyn Heights, NY 11577 Phone: 516-395-5514 |
Roslyn Dental, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 70 Glen Cove Road, Suite 103, Roslyn Heights, NY 11577 Phone: 516-621-3777 |
Dental Associates For Kids Only Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 216 Willis Ave, Roslyn Heights, NY 11577 Phone: 516-625-3806 Fax: 516-625-6845 |
Sleep Better, Live Better Inc. Dentist Medicare: Not Enrolled in Medicare Practice Location: 250 S Service Rd Ste B150, Roslyn Heights, NY 11577 Phone: 516-626-1301 Fax: 888-206-5174 |
Da Vinci Dental Arts P.c. Dentist Medicare: Not Enrolled in Medicare Practice Location: 143 Mineola Ave, Roslyn Heights, NY 11577 Phone: 516-877-7771 Fax: 516-280-4948 |
Susanna Isaacs Dds, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 143 Mineola Ave, Roslyn Heights, NY 11577 Phone: 718-510-2255 |
News Archive
Researchers to determine levels of stroke risk in patients with narrowed brain arteries
Neurological researchers at Rush University Medical Center are part of a multicenter, National Institutes of Health (NIH) study to determine the levels of stroke risk and stroke recurrence in patients with narrowed brain arteries.
CBIS shares owned by Cannex Therapeutics to be cancelled and re-issued to K&D
Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products announces Federal Court order for CBIS shares owned by Cannex Therapeutics controlled by Steve Kubby to be cancelled and re-issued to K&D. Both K&D and Cannabis Science denounce the "slanderous, malicious attacks" on the Company by its fired CEO Steve Kubby.
K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs
K.U.Leuven announced today that on July 29th, 2010 they entered into a license agreement with Pfizer. The license agreement grants Pfizer exclusive and sublicenseable worldwide rights to further develop and commercialise K.U.Leuven's compounds with a new mechanism of action for the potential treatment of individuals infected with HIV, the virus that causes AIDS.
Tips to optimize your health care budget this year
You can help lower your out-of-pocket health care costs by understanding what your health plan covers, what it does not cover and how to make the most of every dollar spent on health care and health insurance.
ZenBio awarded Phase I SBIR grant to establish novel human cell-based models of NAFLD
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
› Verified 8 days ago